Topoisomerase Inhibitors Flashcards
Topoisomerase I inhibitors
MOA: bind DNA topo I interfere w/ nicked DNA ligation. Camptothecins: topotecan, irinotecan
Camptothecins
Topotecan
Irinotecan
Podophyllotoxins
Etoposide
Teniposide
Topoisomerase II inhibitors
MOA: bind DNA topo II interfere w/ nicked DNA ligation
Podophyllotoxins: etoposide, teniposide
Topoisomerases vs. Anticancer Abx
Topoisomerases are obtained from plant sources and drug binds only when DNA and topoisomerase are together
Abx are obtained from microbial source and intercalate w/ DNA so it is already there (bound) to DNA and not just when topoisomerase and DNA are together
Camptothecins
Limited water solubility
Sodium salt that opens lactone ring makes it more soluble, but it is also more toxic*(hemorrhagic cystitis) and less active
Topotecan
Topotecan itself is active
*lactone hydrolysis (dihydroxy acid->major active metabolite)Reversible
Highly plasma protein bound
DDI: inhibitors of BCRP and P-gp and CYP3A4
Toxicity: myelosuppression, diarrhea, mucositis
Irinotecan
Prodrug carbamate ester
SN-38 is active metabolite
hepatic carboxyesterase converts to active SN-38
UGT1A128/6 mutation has low enzyme activity leading to toxicity because SN-38 doesn’t get converted to inactive SN-38G
Toxicity: acute and delayed diarrhea (dose limiting), myelosuppression, N/V
Epipodphyllotoxin
*lactone hydrolysis (hydroxy acid metabolite) is the major active metabolite
Toxicity: mucositis, myelosuppression
N/V is milder
Epipodphyllotoxin lipophilic compounds
Enhanced uptake but poor solubility
Solubility enhancer (cremophor-> hypersensitivity rxn)
Etoposide: PO, IV( phosphate)
Teniposide: IV only. Has a thiol group that makes it more lipophilic than etoposide
Mechanism of resistance to Topoisomerase inhibitors
- Down regulation of target enzyme or receptors (topo I or topo IIa)
- Down regulation of activation enzymes ( hepatic irinotecan converting enzyme)
- Cellular efflux (Camptothecins- BCRP, MDRP, P-Gp. Epipodophyllotoxins- P-gp)